| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 1, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 48,565 | $54.02 | $2,623,481.30 | View Details Filing |
| Apr 30, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 2,141 | $54.01 | $115,635.41 | View Details Filing |
| Apr 29, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 22,544 | $54.01 | $1,217,601.44 | View Details Filing |
| Apr 28, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 113,673 | $51.47 | $5,850,749.31 | View Details Filing |
| Apr 28, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 74,635 | $50.43 | $3,763,843.05 | View Details Filing |
| Apr 28, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 51,750 | $54.02 | $2,795,535.00 | View Details Filing |
| Apr 28, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 243,596 | $52.02 | $12,671,863.92 | View Details Filing |
| Apr 6, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | S | 7,278 | $50.01 | $363,972.78 | View Details Filing |